Pulmonary metastases of breast carcinomas: Ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival

Pulmonary metastases of breast carcinomas have a high frequency and are often subject to surgical intervention. To contribute to advances in the knowledge about morphometric and biochemical parameters of primary tumors and their metastatic lesions, analysis of syntactic structure and thermodymanic aspects as well as of expression of distinct glycohistochemical features with respect to period of metastasis occurrence and patient survival is desirable.

[1]  I D Bross,et al.  Cancer of the breast: Size of neoplasm and prognosis , 1969, Cancer.

[2]  H. Kahn,et al.  Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases. , 1985, The American journal of pathology.

[3]  G. Dekan,et al.  Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors. , 1996, The Journal of thoracic and cardiovascular surgery.

[4]  G. Friedel,et al.  The Significance of Prognostic Factors for the Resection of Pulmonary Metastases of Breast Cancer , 1994, The Thoracic and cardiovascular surgeon.

[5]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[6]  H. Gabius,et al.  Phenotype-associated lectin-binding profiles of normal and transformed blood cells: a comparative analysis of mannose- and galactose-binding lectins from plants and human serum/placenta. , 1994, European journal of cell biology.

[7]  S. Carlsen,et al.  Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma. , 1988, Cancer research.

[8]  C. Begg,et al.  Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. , 1996, The Annals of thoracic surgery.

[9]  K. Kayser,et al.  Disease type-associated increases of the plasma levels and ligand expression for natural alpha- or beta-galactoside-binding immunoglobulin G subfractions in patients with lung cancer. , 1997, International journal of oncology.

[10]  M Tubiana,et al.  The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. , 1989, British Journal of Cancer.

[11]  A. Schauer,et al.  Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[12]  Detection and quantification of carbohydrate-binding sites on cell surfaces and in tissue sections by neoglycoproteins. , 1994, Methods in enzymology.

[13]  H. Gabius,et al.  Concepts of tumor lectinology. , 1997, Cancer investigation.

[14]  Klaus Kayser,et al.  Analytical lung pathology , 1992 .

[15]  K Kayser,et al.  Integrated optical density and entropiefluss (current of entropy) in bronchial carcinoma. , 1993, In vivo.

[16]  H. Gabius,et al.  Purification and properties of a Ca2+-independent sialic acid-binding lectin from human placenta with preferential affinity to O-acetylsialic acids. , 1989, The Journal of biological chemistry.

[17]  H. Gabius,et al.  Quantitation of endogenous lectin expression in 3LL tumors, growing subcutaneously and in the kidneys of mice , 1990, International journal of cancer.

[18]  J F Vliegenthart,et al.  Molecular dynamics-derived conformation and intramolecular interaction analysis of the N-acetyl-9-O-acetylneuraminic acid-containing ganglioside GD1a and NMR-based analysis of its binding to a human polyclonal immunoglobulin G fraction with selectivity for O-acetylated sialic acids. , 1996, Glycobiology.

[19]  K Kayser,et al.  Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its alpha 2,3/alpha 2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice. , 1997, Bioconjugate chemistry.

[20]  S. Joshi,et al.  Analysis of cell‐surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic‐immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems , 1990, International journal of cancer.

[21]  P. Goss,et al.  Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes. , 1996, Journal of Clinical Oncology.

[22]  K. Kayser,et al.  Graph Theory and the EntropyConcept in Histochemistry , 1997 .

[23]  K Kayser,et al.  Carcinoid tumors of the lung: Immuno‐ and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically , 1996, Journal of surgical oncology.

[24]  J. Starkey,et al.  The role of tumor‐cell surface carbohydrate in experimental metastasis , 1986, International journal of cancer.

[25]  L. Andersson,et al.  Different lectin‐binding patterns in primary breast cancers and their metastases , 1990, Cancer.

[26]  K Kayser,et al.  Correlation of expression of binding sites for synthetic blood group A-, B- and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. , 1994, European journal of cancer.

[27]  J. Le Pendu,et al.  Correlation between cell surface oligosaccharides and tissue target-selective adhesion of two rat adenocarcinoma cell lines. , 1990, Invasion & metastasis.

[28]  G Haroske,et al.  Cellular sociology of proliferating tumor cells in invasive ductal breast cancer. , 1996, Analytical and quantitative cytology and histology.

[29]  P. Furmanski,et al.  Prognostic value of concanavalin A reactivity of primary human breast cancer cells. , 1981, Cancer research.

[30]  K Kayser,et al.  Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. , 1993, Histology and histopathology.

[31]  J Isola,et al.  Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.